European research led by University College London (UCL), together with Amsterdam UMC and the University of Basel, shows that ...

or bradycardia are commonly seen in patients undergoing CEA owing to the proximity of the carotid sinus baroreceptor to the area of the endarterectomy procedure (ie, the carotid bulb). Lidocaine ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Sonolysis ...

Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid st ...

The most effective treatment for carotid artery stenosis is carotid endarterectomy (CEA). To date, randomized trials of this procedure versus best medical care have excluded patients aged 80 years ...

Using ultrasound during surgery to unblock carotid arteries is a safe and effective way to significantly reduce the risk of ...

Carotid Endarterectomy - For patients with significant carotid artery narrowing with or without stroke-like symptoms, surgery may be recommended. Carotid Endarterectomy surgery involves exposing the ...

For patients undergoing carotid endarterectomy ... Participants were randomly assigned to receive sonolysis or sham procedure (507 and 497 individuals, respectively). The composite incidence ...

Applying ultrasound to help break up thrombus during carotid endarterectomy reduces adverse neurological outcomes in the first 30 days after surgery in patients with either symptomatic or asymptomatic ...

We are very pleased to be working with NAMSA and leveraging their vascular clinical and regulatory expertise to execute this important study as efficiently as possible.” Acco ...

Sonolysis was safe; 30 days after the procedure, 94.4 percent of patients ... risk of periprocedural cerebrovascular events during carotid endarterectomy in all patients with sufficient temporal ...

For patients undergoing carotid endarterectomy, sonolysis is safe and results in a significant reduction in cerebrovascular events and death within 30 days.